Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil
Open Access
- 29 October 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 114, 58-61
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- FAPERJ
- Ministry of Health
- Ministério da Ciência Tecnologia e Inovação
- INCT-FCx
This publication has 12 references indexed in Scilit:
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in ChileNew England Journal of Medicine, 2021
- Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control studyThe Lancet Regional Health - Americas, 2021
- Assignment of epidemiological lineages in an emerging pandemic using the pangolin toolVirus Evolution, 2021
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseScience, 2021
- Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, BrazilEmerging Infectious Diseases, 2021
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)The Lancet, 2021
- Post-acute COVID-19 syndromeNature Medicine, 2021
- Management of post-acute covid-19 in primary careBMJ, 2020
- Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020Eurosurveillance, 2020
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0Systematic Biology, 2010